New products
Nightingale Health and Genom to launch risk detection test in Croatia
Nightingale Health and Genom have partnered to launch a blood-based risk detection test in Croatian clinics and laboratories. The test leverages biomarker analysis to identify disease risk in patient populations. The partnership expands Nightingale's diagnostic footprint in Central Europe through Genom's local laboratory network.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network